At this year’s ACHEMA trade show (10–14 June, Frankfurt, Germany), experts from GEA — one of the world’s largest suppliers of systems and components to the food, beverage and pharmaceutical industries — will highlight how they’re advancing industrial manufacturing with groundbreaking technology and adapting processes for a better future.
As a trusted supplier of cutting-edge tableting equipment, the NexGen Press range represents the future of tablet compression for the pharmaceutical industry. GEA experts have combined the very best aspects of its existing lines into a family of machines that stands for next-generation tablet compression.
“Our mission is to revolutionize the way businesses operate by leveraging cutting-edge technologies and sustainable practices to enhance productivity and minimize environmental impact,” said Dr Jim Holman, Senior Director for Technology Management, Solid Dosage, at GEA.
“We believe in the power of transformation to meet the demands of the present and to shape the world of tomorrow.”
Building on the Add Better label-winning NexGen Press 30, the larger NexGen Press 45 offers the same benefits as its smaller sibling, such as the flexibility to adapt to any containment level (up to OEB5) — thanks to the FAST CHANGEOVER Exchangeable Compression Module (FCO ECM).
It can also be equipped with the same option packs, making it an extremely agile production system that can be tailored to accommodate a wide range of tableting applications (MUPS, bilayer, poorly flowing products, high yield, microtablets, etc.) and/or different cleaning strategies (wash offline or inline).
In addition, every machine in the NexGen Press range is equipped with six compression modes and benefits from GEA’s unique Air Compensator technology, effectively reducing common compression issues.
“With a maximum output capacity of more the 500,000 tablets per hour, this high-speed large-scale machine is a significant addition to the NexGen Press® portfolio,” Jim commented.
